Peloton Equity

The firm is led by its founding partners, a group that has worked together for over 20 years going back to Ferrer Freeman & Company. Day-to-day investment decisions are made by the managing partner and partner team in Greenwich. The firm does not publicly name individual decision-makers beyond broad team titles on its website.

Peloton focuses on lower-middle-market companies with proven business models and revenue typically between $10 million and $200 million. It invests across healthcare subsectors including data analytics, digital health, medical devices, post-acute care, and cold-chain logistics. Portfolio examples are Arcadia (analytics), Grenova (sustainable lab solutions), and ClearSky Health (inpatient rehabilitation).

Peloton describes its approach as growth capital, often partnering with management teams at a post-venture, pre-buyout stage. While the firm aims for significant influence, it does not uniformly pursue buyout control. Its playbook emphasizes building infrastructure, recruiting management, and pursuing accretive M&A alongside founders and existing leadership.

Peloton leans on a curated network it calls Peloton Nation — more than 200 healthcare leaders who generate investment themes, test diligence, and surface off-market opportunities. On average, nine members contribute to due diligence per deal. This network has also placed over 50 board members and C-suite executives into portfolio companies post-investment.

Peloton closed its second fund, Peloton Equity II, L.P., with $152.25 million in limited-partner and general-partner commitments. The firm has not publicly disclosed total assets under management or a target for a subsequent fund.

Peloton was founded in 2014 as the successor firm to Ferrer Freeman & Company, one of the early healthcare growth-equity firms. Peloton's founding partners previously invested together at Ferrer Freeman for more than 20 years, and the current firm explicitly builds on that track record and network.

Yes. Peloton routinely co-invests with strategic and financial partners. For example, Merck Global Health Innovation Fund, Hamilton Lane, Flexstone Partners, and Wave Equity Partners participated alongside Peloton in AeroSafe Global's $43 million funding round. The firm also partnered with Lightyear Capital on the recapitalization of HPOne and with Blue Wolf Capital Partners on the formation of ClearSky Health.